Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.44 Analyst target: $8.58 Upside: 251.64%
Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company is headquartered in Cranbury, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.